ADDENDUMAddendum • February 22nd, 2017 • American BriVision (Holding) Corp • Pharmaceutical preparations
This ADDENDUM (this “Addendum”) dated January 12th , 2017 (the “Effective Date”) to the Collaborative Agreement dated December 29, 2015 (as amended hereby, the “Agreement”) by and between BioLite, Inc., a company incorporated under the laws of Taiwan and having its principal place of business at 3rd Floor, 248, Nei-Hu Road, Sec. l , Taipei, 11493 Taiwan (“BioLite”) and American BriVision Corporation, a Delaware corporation having its principle place of business at 11, Sawyer Park Drive, Goshen, New York 10294 USA (“ABVC”). BioLite and ABVC are thereafter referred to as the “Parties”.
